About The Medical Condition EN-1639A
Find the definition of the medical term EN-1639A. EN-1639A defined and explained for easy understanding at the Medical Conditions from ClusterMed.info.
EN-1639A
| EN-1639A Medical Condition |
|---|
What's The Definition Of The Medical Condition EN-1639A?
Derivative of noroxymorphone that is the N-cyclopropylmethyl congener of NALOXONE. It is a narcotic antagonist that is effective orally, longer lasting and more potent than naloxone, and has been proposed for the treatment of heroin addiction. The FDA has approved naltrexone for the treatment of alcohol dependence.
|
More Medical Conditions
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Medical Conditions Definitions Of The Day
- Vitamin D-Resistant Rickets ‐ Familial disorder characterized by hypophosphatemia associated…
- Skin Diseases, Parasitic ‐ Skin diseases caused by arthropods, helminths, or…
- Outtakes (PT) ‐ Untitled raw motion picture and video footage which has not been…
- Oxidative Phosphorylations ‐ Electron transfer through the cytochrome system liberating free…
- Iodotyrosine ‐ A product from the iodination of tyrosine. In the biosynthesis…
- Beta-1 Subunit, Integrin ‐ Integrin beta-1 chains which are expresssed as heterodimers noncovalently…
- Cell Lineages ‐ The developmental history of cells as traced from the first division…
- Leukemias, Acute Myelocytic ‐ Progressive, malignant disease of the myeloid tissue in which…
- Antiaggregants, Platelet ‐ Drugs or agents which antagonize or impair any mechanism leading…
- Rev-Responsive Elements, HIV ‐ DNA sequences that form the coding region for the viral envelope…